ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Carbapenem Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-32Q9563
Home | Market Reports | Health| Pharmacy
Global Carbapenem Market Insights Forecast to 2028
BUY CHAPTERS

Global Carbapenem Market Insights, Forecast to 2030

Code: QYRE-Auto-32Q9563
Report
December 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Savior Lifetec
Sun Pharmaceutical Industries
Kopran
Hisun Pharmaceutical
Haibin Pharmaceutical
United Lab

The global Carbapenem market is projected to grow from US$ 3780 million in 2024 to US$ 5002.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.

Carbapenem Market

Carbapenem Market

Carbapenems are broad-spectrum antibiotics. That is, they are effective against many types of bacteria, including bacteria that are resistant to many other antibiotics. Carbapenems include the following: Doripenem. Ertapenem.
The US & Canada market for Carbapenem is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Carbapenem is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Carbapenem is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Carbapenem include Pfizer, Savior Lifetec, Sun Pharmaceutical Industries, Kopran, HISUN Pharmaceutical, Haibin Pharmaceutical and United Lab, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Carbapenem, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Carbapenem, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Carbapenem, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Carbapenem sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Carbapenem market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Carbapenem sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Carbapenem Market Report

Report Metric Details
Report Name Carbapenem Market
Accounted market size in 2024 US$ 3780 million
Forecasted market size in 2030 US$ 5002.2 million
CAGR 4.8
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hosptials
  • Clinics
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sun Pharmaceutical Industries, Kopran, HISUN Pharmaceutical, Haibin Pharmaceutical, United Lab
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Carbapenem in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Carbapenem manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Carbapenem sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Carbapenem Market growing?

Ans: The Carbapenem Market witnessing a CAGR of 4.8 during the forecast period 2025-2030.

What is the Carbapenem Market size in 2030?

Ans: The Carbapenem Market size in 2030 will be US$ 5002.2 million.

Who are the main players in the Carbapenem Market report?

Ans: The main players in the Carbapenem Market are Sun Pharmaceutical Industries, Kopran, HISUN Pharmaceutical, Haibin Pharmaceutical, United Lab

What are the Application segmentation covered in the Carbapenem Market report?

Ans: The Applications covered in the Carbapenem Market report are Hosptials, Clinics, Others

What are the Type segmentation covered in the Carbapenem Market report?

Ans: The Types covered in the Carbapenem Market report are Meropenem, Doripenem, Imipenem, Panipenem, Others

Recommended Reports

Carbapenem & Penem Antibiotics

Broad-Spectrum Antibiotics

Hospital Therapeutics & Devices

1 Study Coverage
1.1 Carbapenem Product Introduction
1.2 Market by Type
1.2.1 Global Carbapenem Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Meropenem
1.2.3 Doripenem
1.2.4 Imipenem
1.2.5 Panipenem
1.2.6 Others
1.3 Market by Application
1.3.1 Global Carbapenem Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hosptials
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Carbapenem Sales Estimates and Forecasts 2019-2030
2.2 Global Carbapenem Revenue by Region
2.2.1 Global Carbapenem Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Carbapenem Revenue by Region (2019-2024)
2.2.3 Global Carbapenem Revenue by Region (2025-2030)
2.2.4 Global Carbapenem Revenue Market Share by Region (2019-2030)
2.3 Global Carbapenem Sales Estimates and Forecasts 2019-2030
2.4 Global Carbapenem Sales by Region
2.4.1 Global Carbapenem Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Carbapenem Sales by Region (2019-2024)
2.4.3 Global Carbapenem Sales by Region (2025-2030)
2.4.4 Global Carbapenem Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Carbapenem Sales by Manufacturers
3.1.1 Global Carbapenem Sales by Manufacturers (2019-2024)
3.1.2 Global Carbapenem Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Carbapenem in 2023
3.2 Global Carbapenem Revenue by Manufacturers
3.2.1 Global Carbapenem Revenue by Manufacturers (2019-2024)
3.2.2 Global Carbapenem Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Carbapenem Revenue in 2023
3.3 Global Key Players of Carbapenem, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Carbapenem Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Carbapenem Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Carbapenem, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Carbapenem, Product Offered and Application
3.8 Global Key Manufacturers of Carbapenem, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Carbapenem Sales by Type
4.1.1 Global Carbapenem Historical Sales by Type (2019-2024)
4.1.2 Global Carbapenem Forecasted Sales by Type (2025-2030)
4.1.3 Global Carbapenem Sales Market Share by Type (2019-2030)
4.2 Global Carbapenem Revenue by Type
4.2.1 Global Carbapenem Historical Revenue by Type (2019-2024)
4.2.2 Global Carbapenem Forecasted Revenue by Type (2025-2030)
4.2.3 Global Carbapenem Revenue Market Share by Type (2019-2030)
4.3 Global Carbapenem Price by Type
4.3.1 Global Carbapenem Price by Type (2019-2024)
4.3.2 Global Carbapenem Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Carbapenem Sales by Application
5.1.1 Global Carbapenem Historical Sales by Application (2019-2024)
5.1.2 Global Carbapenem Forecasted Sales by Application (2025-2030)
5.1.3 Global Carbapenem Sales Market Share by Application (2019-2030)
5.2 Global Carbapenem Revenue by Application
5.2.1 Global Carbapenem Historical Revenue by Application (2019-2024)
5.2.2 Global Carbapenem Forecasted Revenue by Application (2025-2030)
5.2.3 Global Carbapenem Revenue Market Share by Application (2019-2030)
5.3 Global Carbapenem Price by Application
5.3.1 Global Carbapenem Price by Application (2019-2024)
5.3.2 Global Carbapenem Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Carbapenem Market Size by Type
6.1.1 US & Canada Carbapenem Sales by Type (2019-2030)
6.1.2 US & Canada Carbapenem Revenue by Type (2019-2030)
6.2 US & Canada Carbapenem Market Size by Application
6.2.1 US & Canada Carbapenem Sales by Application (2019-2030)
6.2.2 US & Canada Carbapenem Revenue by Application (2019-2030)
6.3 US & Canada Carbapenem Market Size by Country
6.3.1 US & Canada Carbapenem Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Carbapenem Sales by Country (2019-2030)
6.3.3 US & Canada Carbapenem Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Carbapenem Market Size by Type
7.1.1 Europe Carbapenem Sales by Type (2019-2030)
7.1.2 Europe Carbapenem Revenue by Type (2019-2030)
7.2 Europe Carbapenem Market Size by Application
7.2.1 Europe Carbapenem Sales by Application (2019-2030)
7.2.2 Europe Carbapenem Revenue by Application (2019-2030)
7.3 Europe Carbapenem Market Size by Country
7.3.1 Europe Carbapenem Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Carbapenem Sales by Country (2019-2030)
7.3.3 Europe Carbapenem Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Carbapenem Market Size
8.1.1 China Carbapenem Sales (2019-2030)
8.1.2 China Carbapenem Revenue (2019-2030)
8.2 China Carbapenem Market Size by Application
8.2.1 China Carbapenem Sales by Application (2019-2030)
8.2.2 China Carbapenem Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Carbapenem Market Size by Type
9.1.1 Asia Carbapenem Sales by Type (2019-2030)
9.1.2 Asia Carbapenem Revenue by Type (2019-2030)
9.2 Asia Carbapenem Market Size by Application
9.2.1 Asia Carbapenem Sales by Application (2019-2030)
9.2.2 Asia Carbapenem Revenue by Application (2019-2030)
9.3 Asia Carbapenem Sales by Region
9.3.1 Asia Carbapenem Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Carbapenem Revenue by Region (2019-2030)
9.3.3 Asia Carbapenem Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Carbapenem Market Size by Type
10.1.1 Middle East, Africa and Latin America Carbapenem Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Carbapenem Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Carbapenem Market Size by Application
10.2.1 Middle East, Africa and Latin America Carbapenem Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Carbapenem Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Carbapenem Sales by Country
10.3.1 Middle East, Africa and Latin America Carbapenem Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Carbapenem Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Carbapenem Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Carbapenem Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pfizer Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Savior Lifetec
11.2.1 Savior Lifetec Company Information
11.2.2 Savior Lifetec Overview
11.2.3 Savior Lifetec Carbapenem Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Savior Lifetec Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Savior Lifetec Recent Developments
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Information
11.3.2 Sun Pharmaceutical Industries Overview
11.3.3 Sun Pharmaceutical Industries Carbapenem Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sun Pharmaceutical Industries Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharmaceutical Industries Recent Developments
11.4 Kopran
11.4.1 Kopran Company Information
11.4.2 Kopran Overview
11.4.3 Kopran Carbapenem Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Kopran Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kopran Recent Developments
11.5 HISUN Pharmaceutical
11.5.1 HISUN Pharmaceutical Company Information
11.5.2 HISUN Pharmaceutical Overview
11.5.3 HISUN Pharmaceutical Carbapenem Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 HISUN Pharmaceutical Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 HISUN Pharmaceutical Recent Developments
11.6 Haibin Pharmaceutical
11.6.1 Haibin Pharmaceutical Company Information
11.6.2 Haibin Pharmaceutical Overview
11.6.3 Haibin Pharmaceutical Carbapenem Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Haibin Pharmaceutical Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Haibin Pharmaceutical Recent Developments
11.7 United Lab
11.7.1 United Lab Company Information
11.7.2 United Lab Overview
11.7.3 United Lab Carbapenem Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 United Lab Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 United Lab Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Carbapenem Industry Chain Analysis
12.2 Carbapenem Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Carbapenem Production Mode & Process
12.4 Carbapenem Sales and Marketing
12.4.1 Carbapenem Sales Channels
12.4.2 Carbapenem Distributors
12.5 Carbapenem Customers
13 Market Dynamics
13.1 Carbapenem Industry Trends
13.2 Carbapenem Market Drivers
13.3 Carbapenem Market Challenges
13.4 Carbapenem Market Restraints
14 Key Findings in The Global Carbapenem Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Savior Lifetec
Sun Pharmaceutical Industries
Kopran
Hisun Pharmaceutical
Haibin Pharmaceutical
United Lab
List of Tables
    Table 1. Global Carbapenem Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Meropenem
    Table 3. Major Manufacturers of Doripenem
    Table 4. Major Manufacturers of Imipenem
    Table 5. Major Manufacturers of Panipenem
    Table 6. Major Manufacturers of Others
    Table 7. Global Carbapenem Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Carbapenem Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 9. Global Carbapenem Revenue by Region (2019-2024) & (US$ Million)
    Table 10. Global Carbapenem Revenue by Region (2025-2030) & (US$ Million)
    Table 11. Global Carbapenem Revenue Market Share by Region (2019-2024)
    Table 12. Global Carbapenem Revenue Market Share by Region (2025-2030)
    Table 13. Global Carbapenem Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Carbapenem Sales by Region (2019-2024) & (K Units)
    Table 15. Global Carbapenem Sales by Region (2025-2030) & (K Units)
    Table 16. Global Carbapenem Sales Market Share by Region (2019-2024)
    Table 17. Global Carbapenem Sales Market Share by Region (2025-2030)
    Table 18. Global Carbapenem Sales by Manufacturers (2019-2024) & (K Units)
    Table 19. Global Carbapenem Sales Share by Manufacturers (2019-2024)
    Table 20. Global Carbapenem Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 21. Global Carbapenem Revenue Share by Manufacturers (2019-2024)
    Table 22. Global Key Players of Carbapenem, Industry Ranking, 2022 VS 2023 VS 2024
    Table 23. Carbapenem Price by Manufacturers 2019-2024 (USD/Unit)
    Table 24. Global Carbapenem Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Carbapenem by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem as of 2023)
    Table 26. Global Key Manufacturers of Carbapenem, Manufacturing Base Distribution and Headquarters
    Table 27. Global Key Manufacturers of Carbapenem, Product Offered and Application
    Table 28. Global Key Manufacturers of Carbapenem, Date of Enter into This Industry
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Carbapenem Sales by Type (2019-2024) & (K Units)
    Table 31. Global Carbapenem Sales by Type (2025-2030) & (K Units)
    Table 32. Global Carbapenem Sales Share by Type (2019-2024)
    Table 33. Global Carbapenem Sales Share by Type (2025-2030)
    Table 34. Global Carbapenem Revenue by Type (2019-2024) & (US$ Million)
    Table 35. Global Carbapenem Revenue by Type (2025-2030) & (US$ Million)
    Table 36. Global Carbapenem Revenue Share by Type (2019-2024)
    Table 37. Global Carbapenem Revenue Share by Type (2025-2030)
    Table 38. Carbapenem Price by Type (2019-2024) & (USD/Unit)
    Table 39. Global Carbapenem Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 40. Global Carbapenem Sales by Application (2019-2024) & (K Units)
    Table 41. Global Carbapenem Sales by Application (2025-2030) & (K Units)
    Table 42. Global Carbapenem Sales Share by Application (2019-2024)
    Table 43. Global Carbapenem Sales Share by Application (2025-2030)
    Table 44. Global Carbapenem Revenue by Application (2019-2024) & (US$ Million)
    Table 45. Global Carbapenem Revenue by Application (2025-2030) & (US$ Million)
    Table 46. Global Carbapenem Revenue Share by Application (2019-2024)
    Table 47. Global Carbapenem Revenue Share by Application (2025-2030)
    Table 48. Carbapenem Price by Application (2019-2024) & (USD/Unit)
    Table 49. Global Carbapenem Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 50. US & Canada Carbapenem Sales by Type (2019-2024) & (K Units)
    Table 51. US & Canada Carbapenem Sales by Type (2025-2030) & (K Units)
    Table 52. US & Canada Carbapenem Revenue by Type (2019-2024) & (US$ Million)
    Table 53. US & Canada Carbapenem Revenue by Type (2025-2030) & (US$ Million)
    Table 54. US & Canada Carbapenem Sales by Application (2019-2024) & (K Units)
    Table 55. US & Canada Carbapenem Sales by Application (2025-2030) & (K Units)
    Table 56. US & Canada Carbapenem Revenue by Application (2019-2024) & (US$ Million)
    Table 57. US & Canada Carbapenem Revenue by Application (2025-2030) & (US$ Million)
    Table 58. US & Canada Carbapenem Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 59. US & Canada Carbapenem Revenue by Country (2019-2024) & (US$ Million)
    Table 60. US & Canada Carbapenem Revenue by Country (2025-2030) & (US$ Million)
    Table 61. US & Canada Carbapenem Sales by Country (2019-2024) & (K Units)
    Table 62. US & Canada Carbapenem Sales by Country (2025-2030) & (K Units)
    Table 63. Europe Carbapenem Sales by Type (2019-2024) & (K Units)
    Table 64. Europe Carbapenem Sales by Type (2025-2030) & (K Units)
    Table 65. Europe Carbapenem Revenue by Type (2019-2024) & (US$ Million)
    Table 66. Europe Carbapenem Revenue by Type (2025-2030) & (US$ Million)
    Table 67. Europe Carbapenem Sales by Application (2019-2024) & (K Units)
    Table 68. Europe Carbapenem Sales by Application (2025-2030) & (K Units)
    Table 69. Europe Carbapenem Revenue by Application (2019-2024) & (US$ Million)
    Table 70. Europe Carbapenem Revenue by Application (2025-2030) & (US$ Million)
    Table 71. Europe Carbapenem Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 72. Europe Carbapenem Revenue by Country (2019-2024) & (US$ Million)
    Table 73. Europe Carbapenem Revenue by Country (2025-2030) & (US$ Million)
    Table 74. Europe Carbapenem Sales by Country (2019-2024) & (K Units)
    Table 75. Europe Carbapenem Sales by Country (2025-2030) & (K Units)
    Table 76. China Carbapenem Sales by Type (2019-2024) & (K Units)
    Table 77. China Carbapenem Sales by Type (2025-2030) & (K Units)
    Table 78. China Carbapenem Revenue by Type (2019-2024) & (US$ Million)
    Table 79. China Carbapenem Revenue by Type (2025-2030) & (US$ Million)
    Table 80. China Carbapenem Sales by Application (2019-2024) & (K Units)
    Table 81. China Carbapenem Sales by Application (2025-2030) & (K Units)
    Table 82. China Carbapenem Revenue by Application (2019-2024) & (US$ Million)
    Table 83. China Carbapenem Revenue by Application (2025-2030) & (US$ Million)
    Table 84. Asia Carbapenem Sales by Type (2019-2024) & (K Units)
    Table 85. Asia Carbapenem Sales by Type (2025-2030) & (K Units)
    Table 86. Asia Carbapenem Revenue by Type (2019-2024) & (US$ Million)
    Table 87. Asia Carbapenem Revenue by Type (2025-2030) & (US$ Million)
    Table 88. Asia Carbapenem Sales by Application (2019-2024) & (K Units)
    Table 89. Asia Carbapenem Sales by Application (2025-2030) & (K Units)
    Table 90. Asia Carbapenem Revenue by Application (2019-2024) & (US$ Million)
    Table 91. Asia Carbapenem Revenue by Application (2025-2030) & (US$ Million)
    Table 92. Asia Carbapenem Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 93. Asia Carbapenem Revenue by Region (2019-2024) & (US$ Million)
    Table 94. Asia Carbapenem Revenue by Region (2025-2030) & (US$ Million)
    Table 95. Asia Carbapenem Sales by Region (2019-2024) & (K Units)
    Table 96. Asia Carbapenem Sales by Region (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Carbapenem Sales by Type (2019-2024) & (K Units)
    Table 98. Middle East, Africa and Latin America Carbapenem Sales by Type (2025-2030) & (K Units)
    Table 99. Middle East, Africa and Latin America Carbapenem Revenue by Type (2019-2024) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Carbapenem Revenue by Type (2025-2030) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Carbapenem Sales by Application (2019-2024) & (K Units)
    Table 102. Middle East, Africa and Latin America Carbapenem Sales by Application (2025-2030) & (K Units)
    Table 103. Middle East, Africa and Latin America Carbapenem Revenue by Application (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Carbapenem Revenue by Application (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Carbapenem Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 106. Middle East, Africa and Latin America Carbapenem Revenue by Country (2019-2024) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Carbapenem Revenue by Country (2025-2030) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Carbapenem Sales by Country (2019-2024) & (K Units)
    Table 109. Middle East, Africa and Latin America Carbapenem Sales by Country (2025-2030) & (K Units)
    Table 110. Pfizer Company Information
    Table 111. Pfizer Description and Major Businesses
    Table 112. Pfizer Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Pfizer Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Pfizer Recent Developments
    Table 115. Savior Lifetec Company Information
    Table 116. Savior Lifetec Description and Major Businesses
    Table 117. Savior Lifetec Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Savior Lifetec Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Savior Lifetec Recent Developments
    Table 120. Sun Pharmaceutical Industries Company Information
    Table 121. Sun Pharmaceutical Industries Description and Major Businesses
    Table 122. Sun Pharmaceutical Industries Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Sun Pharmaceutical Industries Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Sun Pharmaceutical Industries Recent Developments
    Table 125. Kopran Company Information
    Table 126. Kopran Description and Major Businesses
    Table 127. Kopran Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 128. Kopran Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Kopran Recent Developments
    Table 130. HISUN Pharmaceutical Company Information
    Table 131. HISUN Pharmaceutical Description and Major Businesses
    Table 132. HISUN Pharmaceutical Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 133. HISUN Pharmaceutical Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. HISUN Pharmaceutical Recent Developments
    Table 135. Haibin Pharmaceutical Company Information
    Table 136. Haibin Pharmaceutical Description and Major Businesses
    Table 137. Haibin Pharmaceutical Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 138. Haibin Pharmaceutical Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Haibin Pharmaceutical Recent Developments
    Table 140. United Lab Company Information
    Table 141. United Lab Description and Major Businesses
    Table 142. United Lab Carbapenem Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 143. United Lab Carbapenem Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. United Lab Recent Developments
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Carbapenem Distributors List
    Table 148. Carbapenem Customers List
    Table 149. Carbapenem Market Trends
    Table 150. Carbapenem Market Drivers
    Table 151. Carbapenem Market Challenges
    Table 152. Carbapenem Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Carbapenem Product Picture
    Figure 2. Global Carbapenem Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Carbapenem Market Share by Type in 2023 & 2030
    Figure 4. Meropenem Product Picture
    Figure 5. Doripenem Product Picture
    Figure 6. Imipenem Product Picture
    Figure 7. Panipenem Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Carbapenem Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Carbapenem Market Share by Application in 2023 & 2030
    Figure 11. Hosptials
    Figure 12. Clinics
    Figure 13. Others
    Figure 14. Carbapenem Report Years Considered
    Figure 15. Global Carbapenem Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Carbapenem Revenue 2019-2030 (US$ Million)
    Figure 17. Global Carbapenem Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global Carbapenem Revenue Market Share by Region (2019-2030)
    Figure 19. Global Carbapenem Sales 2019-2030 ((K Units)
    Figure 20. Global Carbapenem Sales Market Share by Region (2019-2030)
    Figure 21. US & Canada Carbapenem Sales YoY (2019-2030) & (K Units)
    Figure 22. US & Canada Carbapenem Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Carbapenem Sales YoY (2019-2030) & (K Units)
    Figure 24. Europe Carbapenem Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. China Carbapenem Sales YoY (2019-2030) & (K Units)
    Figure 26. China Carbapenem Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Asia (excluding China) Carbapenem Sales YoY (2019-2030) & (K Units)
    Figure 28. Asia (excluding China) Carbapenem Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America Carbapenem Sales YoY (2019-2030) & (K Units)
    Figure 30. Middle East, Africa and Latin America Carbapenem Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. The Carbapenem Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 32. The Top 5 and 10 Largest Manufacturers of Carbapenem in the World: Market Share by Carbapenem Revenue in 2023
    Figure 33. Global Carbapenem Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 34. Global Carbapenem Sales Market Share by Type (2019-2030)
    Figure 35. Global Carbapenem Revenue Market Share by Type (2019-2030)
    Figure 36. Global Carbapenem Sales Market Share by Application (2019-2030)
    Figure 37. Global Carbapenem Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Carbapenem Sales Market Share by Type (2019-2030)
    Figure 39. US & Canada Carbapenem Revenue Market Share by Type (2019-2030)
    Figure 40. US & Canada Carbapenem Sales Market Share by Application (2019-2030)
    Figure 41. US & Canada Carbapenem Revenue Market Share by Application (2019-2030)
    Figure 42. US & Canada Carbapenem Revenue Share by Country (2019-2030)
    Figure 43. US & Canada Carbapenem Sales Share by Country (2019-2030)
    Figure 44. U.S. Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe Carbapenem Sales Market Share by Type (2019-2030)
    Figure 47. Europe Carbapenem Revenue Market Share by Type (2019-2030)
    Figure 48. Europe Carbapenem Sales Market Share by Application (2019-2030)
    Figure 49. Europe Carbapenem Revenue Market Share by Application (2019-2030)
    Figure 50. Europe Carbapenem Revenue Share by Country (2019-2030)
    Figure 51. Europe Carbapenem Sales Share by Country (2019-2030)
    Figure 52. Germany Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 53. France Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 54. U.K. Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 55. Italy Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 56. Russia Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 57. China Carbapenem Sales Market Share by Type (2019-2030)
    Figure 58. China Carbapenem Revenue Market Share by Type (2019-2030)
    Figure 59. China Carbapenem Sales Market Share by Application (2019-2030)
    Figure 60. China Carbapenem Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Carbapenem Sales Market Share by Type (2019-2030)
    Figure 62. Asia Carbapenem Revenue Market Share by Type (2019-2030)
    Figure 63. Asia Carbapenem Sales Market Share by Application (2019-2030)
    Figure 64. Asia Carbapenem Revenue Market Share by Application (2019-2030)
    Figure 65. Asia Carbapenem Revenue Share by Region (2019-2030)
    Figure 66. Asia Carbapenem Sales Share by Region (2019-2030)
    Figure 67. Japan Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 68. South Korea Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 69. China Taiwan Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 70. Southeast Asia Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 71. India Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America Carbapenem Sales Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Carbapenem Revenue Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Carbapenem Sales Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Carbapenem Revenue Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Carbapenem Revenue Share by Country (2019-2030)
    Figure 77. Middle East, Africa and Latin America Carbapenem Sales Share by Country (2019-2030)
    Figure 78. Brazil Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 79. Mexico Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 80. Turkey Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 81. Israel Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 82. GCC Countries Carbapenem Revenue (2019-2030) & (US$ Million)
    Figure 83. Carbapenem Value Chain
    Figure 84. Carbapenem Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Carbapenem Drugs Market Research Report 2024
Global Penem Antibiotics Market Research Report 2024
Global Carbapenems Drug Intermediates Market Research Report 2024
Carbapenem Based Antibiotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Doripenem Market Insights Forecast to 2030
Global Penem APIs Market Research Report 2024
Global Beta lactam and Beta lactamase Inhibitors Market Research Report 2025
Global Biapenem API Market Research Report 2025
Global Carbapenem resistant Enterobacteriaceae Testing Market Research Report 2024
Global Oral Faropenem Market Research Report 2024
Global Penem APIs and Intermediates Market Research Report 2024
Global Relebactam Market Research Report 2024
Carbapenem API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Penem Antibiotic Intermediates Market Research Report 2024
Global Ertapenem Sodium for Injection Market Research Report 2024
Global Ertapenem Sodium Market Research Report 2024
Global Meropenem Trihydrate Market Research Report 2024
Global Ampicillin Market Insights Forecast to 2030
Global Broad spectrum Antibiotics Market Research Report 2025
Global β Lactam Antibiotics Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions